Medblue Innovations develops non-invasive diagnostic devices, including a jaundice monitoring system for neonates and a pulse oximeter, aimed at improving healthcare access for underserved populations in low- and middle-income countries. The company addresses the lack of affordable and reliable medical technology in the final mile, ensuring timely and effective health monitoring.
Funding
Funding not disclosed
Founders
Product
Problem
In low- and middle-income countries, access to reliable and affordable diagnostic medical devices is limited, hindering timely and effective healthcare monitoring, especially for vulnerable populations like neonates. Existing solutions are often expensive, require specialized training, and are not designed for use in resource-constrained settings.
Solution
Medblue Innovations develops and manufactures non-invasive, affordable diagnostic devices specifically designed for use in low-resource settings. Their initial product line includes a non-invasive neonatal jaundice monitoring system and a pulse oximeter, both engineered for ease of use and reliability in the field. By focusing on accessible technology, Medblue aims to improve healthcare outcomes for underserved populations by enabling early detection and monitoring of critical health conditions. The devices are designed and manufactured in India, emphasizing affordability and local relevance.
Target Audience
The primary target audience includes healthcare providers, hospitals, and NGOs operating in low- and middle-income countries, particularly those serving underserved populations with limited access to advanced medical technology.
Features
- Billisure: A non-invasive device for neonatal jaundice monitoring.
- Pulmosure: A non-invasive pulse oximeter for measuring blood oxygen saturation.
- Devices are designed for ease of use by healthcare workers with minimal training.
- Focus on affordability to ensure accessibility in low- and middle-income countries.
- Manufactured in India to reduce costs and promote local production.